Research programme: targeted RNA therapeutics - Gennao Bio
Alternative Names: Targeted RNA therapeutics - Gennao BioLatest Information Update: 31 Mar 2021
At a glance
- Originator Gennao Bio
- Class Antineoplastics; Drug conjugates; Immunotherapies; Monoclonal antibodies; RNA
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
- Research Musculoskeletal disorders